Castlight and Noom Join Forces to Tackle the GLP-1 Cost Crisis Through Integrated Digital Health
What You Should Know: – Castlight Health and Noom have formed a strategic partnership to embed Noom’s preventive health and weight management programs directly into Castlight’s health navigation platform. – The integration allows employers to purchase Noom through Castlight, granting employees seamless access to psychology-based care and GLP-1 medication management. The move is designed to […]
Health insurance premiums rose nearly 3x the rate of worker earnings over the past 25 years
Patients and employers are feeling the pain of increased health premiums. wildpixel/iStock via Getty Images Plus Health insurance premiums in the U.S. significantly increased between 1999 and 2024, outpacing the rate of worker earnings by three times, according to our newly published research in the journal JAMA Network Open. Premiums can rise if the costs […]
Supplement trends: GLP-1 support, functional beverages, pet health and more
While a lot of attendees come to SupplySide Global to show off their latest innovations, for many, the main objective is to see the latest trends shaping the future of dietary supplements. Nextin Research, a new offering from MarketPlace which conducts surveys to gather insights aimed at connecting the dots between trends, innovation and market […]
Structure Therapuetics surges on phase 2 data for GLP-1 pill aleniglipron
WHO Guidance, GLP-1 Price Curbs Unlikely to Change Practice
A new WHO guideline on GLP-1s and recent efforts to reduce the drugs’ costs now and going forward are unlikely to change US obesity practice – but other actions might. Medscape Medical News
Biotech Soars On Potential ‘Best-In-Class’ Obesity Drug – Investor’s Business Daily
Biotech Soars On Potential ‘Best-In-Class’ Obesity Drug Investor’s Business Daily Structure’s Obesity Pill Delivers Weight-Loss ‘Homerun’ in Study Bloomberg.com Structure reports promising weight loss outcomes with obesity drug, but side effect questions loom statnews.com Structure Therapeutics Stock Jumps on Trial Results for Weight-Loss Pill The Wall Street Journal Structure Therapeutics details positive trial data for a weight-loss pill, and […]
Structure Therapeutics surges on phase 2 data for GLP-1 pill aleniglipron
7 Ways To Naturally Boost GLP-1 Production & Improve Metabolism
GLP-1 support from the grocery store? The research gets interesting
2 Companies Poised to Capitalize on the Rise of GLP-1 Drugs
Why Pfizer and Roche look like top choices for investors in the war to tip the scales.
Her food cravings vanished on Mounjaro then roared back
Deep-brain recordings showed that Mounjaro and Zepbound briefly shut down the craving circuits linked to food noise in a patient with severe obesity. Her obsessive thoughts about food disappeared as the medication quieted the nucleus accumbens, the brain’s reward hub.